The US Food and Drug Administration (FDA) has approved a product known as enzalutamide (Xtandi®) to be used in a new way. The body, after an in-depth review says that it is ideal for handling a condition called prostate cancer (mHSPC). A close outlook Sometime back, the company gave its approval to the product for […]
Michael Jung
Recent Posts
Global Fiber Technologies Secures Second Round of Inventory Financing
RSAMMD ACQUISITIONS LLC AND PROTEXT MOBILITY, INC. (TXTM) PLEASED TO ANNOUNCE ITS CHAIRMAN DR. AHMED JAMALOODEEN HAS RECEIVED THE HIGH HONOR OF BEING APPOINTED AS NATIONAL COMMODITY BOARD CHAIRMAN OF CANNABIS AND ALL INDIGENOUS FLORA
Titan NRG, Inc. (TTNN) Releases Annual Report For Fiscal Year 2021
Mike The Pike Productions, Inc. (OTC: MIKP) Launches Form 10 initiatives Toward Pink Current Status with OTC Markets
Splash Beverage Group Signs Agreement with Mexcor for Full State Distribution of All Three Beverage Alcohol Brands in Texas
